News
Pharmaceutical Technology on MSN1d
SpyGlass Pharma secures $75m for ophthalmic drug delivery platformSpyGlass Pharma has closed a Series D funding round, raising $75m to advance the company's drug delivery platform to offer ...
The tear film coating the eye offers a window into a person's systemic and ocular health, carrying biomarkers such as glucose ...
Secondary IOL implantation improved visual acuity over time across several types of techniques, according to a speaker.At ...
Zacks Investment Research on MSN6d
Alcon Stock Rises Following the FDA Approval of TRYPTYRAlcon ALC recently received Food and Drug Administration (“FDA”) approval for its TRYPTYR (acoltremon ophthalmic solution) 0.003%. TRYPTYR is indicated for the treatment of the signs and symptoms of ...
As millions of Americans reach their 40s and 50s, many begin to experience the frustrating effects of presbyopia—the gradual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback